Other
Available for sale investments
CVS Health Available for sale investments decreased by 1.1% to $28.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.0%, from $26.04B to $28.39B. Over 5 years (FY 2020 to FY 2025), Available for sale investments shows an upward trend with a 6.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2018
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_securities_debt_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.35B | $22.57B | $23.24B | $22.5B | $20.75B | $20.04B | $20.28B | $20.82B | $20.9B | $20.4B | $21.71B | $22.63B | $23.83B | $26.49B | $26.03B | $26.04B | $26.55B | $27.84B | $28.72B | $28.39B |
| QoQ Change | — | +1.0% | +3.0% | -3.2% | -7.8% | -3.4% | +1.2% | +2.7% | +0.4% | -2.4% | +6.4% | +4.2% | +5.3% | +11.2% | -1.7% | +0.0% | +2.0% | +4.8% | +3.2% | -1.1% |
| YoY Change | — | — | — | — | -7.1% | -11.2% | -12.7% | -7.4% | +0.7% | +1.8% | +7.1% | +8.7% | +14.0% | +29.8% | +19.9% | +15.1% | +11.4% | +5.1% | +10.3% | +9.0% |
Range$20.04B – $28.72B
CAGR+5.2%
Avg YoY Growth+5.9%
Median YoY Growth+7.9%
Product Breakdown
| Segment | Q4 '25 |
|---|---|
| Supporting Experience-Rated Products | $475M |
| Total | $28.72B |
Available for sale investments at Other Companies
Frequently Asked Questions
- What is CVS Health's available for sale investments?
- CVS Health (CVS) reported available for sale investments of $28.39B in Q1 2026.
- How has CVS Health's available for sale investments changed year-over-year?
- CVS Health's available for sale investments increased by 9.0% year-over-year, from $26.04B to $28.39B.
- What is the long-term trend for CVS Health's available for sale investments?
- Over 5 years (2020 to 2025), CVS Health's available for sale investments has grown at a 6.3% compound annual growth rate (CAGR), from $21.19B to $28.72B.